Wikidata

(Q62820744)

English

An Efficacy and Safety Study of Alirocumab in Children and Adolescents With Homozygous Familial Hypercholesterolemia

clinical trial

In more languages
default for all languages
No label defined

No description defined

Statements

title
An Open-Label Study to Evaluate the Efficacy and Safety of Alirocumab in Children and Adolescents With Homozygous Familial Hypercholesterolemia (English)
0 references
sponsor
Sanofi
0 references
country
Austria
0 references
Brazil
0 references
Canada
0 references
Denmark
0 references
Italy
0 references
Mexico
0 references
Netherlands
0 references
Norway
0 references
Slovenia
0 references
Spain
0 references
Taiwan
0 references
Turkey
0 references
start time
31 August 2018
0 references
end time
August 2019
0 references
number of participants
18
0 references
research intervention
rosuvastatin calcium
0 references
ezetimibe
0 references
pravastatin
0 references
lovastatin
0 references
colestyramine
0 references
nicotinic acid
0 references
niacinamide
0 references
minimum age
8 year
0 references
maximum age
17 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q62820744&oldid=2149211342"